|
Rep. Sara Feigenholtz
Filed: 3/29/2019
| | 10100HB2259ham001 | | LRB101 09722 KTG 58565 a |
|
|
| 1 | | AMENDMENT TO HOUSE BILL 2259
|
| 2 | | AMENDMENT NO. ______. Amend House Bill 2259 on page 3, |
| 3 | | immediately below line 19, by inserting the following: |
| 4 | | "A licensed physician recommended by the Rare Disease |
| 5 | | Commission who is a rare disease specialist and possesses |
| 6 | | scientific knowledge and medical training with respect to rare |
| 7 | | diseases, and is familiar with drug and biological products and |
| 8 | | treatment, shall be notified in advance to attend an Illinois |
| 9 | | Drug and Therapeutics Advisory Board meeting when a drug or |
| 10 | | biological product is scheduled to be reviewed in order to |
| 11 | | advise and make recommendations on drugs or biological |
| 12 | | products.".
|